Differential effects of venlafaxine in the treatment of major depressive disorder according to baseline severity
✍ Scribed by Andreas B. Schmitt; Michael Bauer; Hans-Peter Volz; Hans-Jürgen Moeller; Qin Jiang; Philip T. Ninan; Peter-Andreas Loeschmann
- Publisher
- Springer-Verlag
- Year
- 2009
- Tongue
- English
- Weight
- 346 KB
- Volume
- 259
- Category
- Article
- ISSN
- 1433-8491
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Repetitive transcranial magnetic stimulation (rTMS) is a relatively new treatment modality for psychiatric patients. rTMS was demonstrated to be effective in the treatment of depression. However, longitudinal outcome studies have not yet been published. Relapse rates are higher in depre
## Abstract ## Objectives This study evaluated the effectiveness and tolerability of paroxetine controlled release (CR) for the treatment of Korean patients with major depressive disorder (MDD) in a naturalistic treatment setting. ## Methods One hundred and ninety patients with MDD were enrolled
## Abstract A previously published model‐free linkage analysis of chromosome 2q33–35, highlighted by previous case–control studies and supported by within‐family analyses employing the transmission disequilibrium test, revealed evidence of sex‐specific linkage of the __CREB1__‐containing region of